Acute Porphyria Drug Database

Monograph

S01FA56 - Tropicamide, Combinations
Propably not porphyrinogenic
PNP

Important Information
Limitations: This safety classification applies only to preparations containing a combination of the two drugs tropicamide and phenylephrine. The same ATC code (S01FA56) can in some countries be used for different combinations of tropicamide and other drugs, which in theory may or may not be porphyrinogenic. Please refer to the classification and monograph of each individual substance.
Rationale
Administered locally in the eye and systemic exposure is insignificant.
Chemical description
Tropicamide is a phenylpropylamide. Phenylephrine is a phenol derivative.
Therapeutic characteristics
Tropicamid in combination with phenylephrine is used to obtain pre-operative mydriasis (dilation of the pupil). It is administered as an ophthalmic insert.
Hepatic exposure
Very low concentrations of phenylephrine and tropicamide were found in eye chamber water, below 6 µg/ml and 3 µg/ml, respectively. Plasma levels of phenylephrine measured during 6 hours in healthy volunteers were not detectable (< 0.5 ng/ml) (SPC). Plasma levels of phenylephedrine were well below 1 µM and hepatic exposure is therefore insignificant.
Metabolism and pharmacokinetics
In oral administration, phenylephrine is metabolized via monoamine oxidase and sulfotransferase and probably no CYP enzymes are involved. No data is found for the metabolism of tropicamide.

References

# Citation details PMID
*Drug interaction databases
1. Lexi-Comp in UpToDate. Phenylephrine: Drug information.
*Summary of Product Characteristics
2. The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). (Mydriasert).

Similar drugs
Explore alternative drugs in similar therapeutic classes S01F / S01FA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Mydrane · Mydrane 0,2 mg/ml + 3,1 mg/ml + 10 mg/ml oplossing voor injectie · Mydriasert · Mydriasert, ooginsert 0,28 mg en 5,4 mg
Belgium
Mydrane · Mydrane 0.2 mg/ml - 10 mg/ml sol. inj. amp. · Mydriasert · Mydriasert 0.28 mg - 5.4 mg insert ophtalm. sachet
United Kingdom
Mydrane · Mydrane 0.2mg/ml / 3.1mg/ml / 10mg/ml solution for injection 0.6ml ampoules · Mydriasert · Mydriasert 5.4mg/0.28mg ophthalmic inserts
Denmark
Mydrane · Mydriasert
Norway
Mydane · Mydrane
Poland
Mydrane
Luxembourg
Mydrane · Mydrane 0,2mg/ml+3,1mg/ml+10mg/ml · MYDRIASERT
Iceland
MYDRANE
Finland
Mydrane · Mydriasert
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙